Dr. Camilo Pena, MD

Dr. Pena practices at Bma South Plains in Lubbock, Texas.

Dr. Pena's NPI, 1194165712, was assigned on June 27, 2013. Dr. Pena graduated from El Bosque University in 2010. Dr. Pena holds Texas license R1273.

Dr. Pena's primary practice is Bma South Plains, at 3601 4th St, Lubbock, TX 79415 in Lubbock County. The practice phone is (806) 793-1414.

Dr. Pena's primary practice is Bma South Plains in Lubbock, Texas. Dr. Pena is also affiliated with University Medical Center. The medical group on file is Texas Tech Physicians. Dmand AI also links Dr. Pena to 3 more dialysis centers, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pena practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Pena's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Pena is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Pena's licenses on file in 8 states: Texas, New Mexico, Colorado, New Jersey, New York, Arkansas, Connecticut and Indiana.

Dmand AI lists acute kidney failure, chronic kidney disease, kidney cysts and kidney failure among the conditions Dr. Pena treats.

CMS data shows 587 Medicare services from Dr. Pena across 8 procedure codes in 2024, for 163 Medicare patients. Medicare paid $73,758 for them.

CMS counts 163 Medicare patients who saw Dr. Pena in 2024. The largest group is under 65, with 62 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 32% are also on Medicaid. Their average risk score is 5.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pena's median patient age at 69, with 43% women.

In 2024, Dr. Pena wrote 576 Medicare Part D claims for 115 patients. 82% of them were for generic drugs. CMS names the drug for 428 of them, across 17 drugs with 11 or more claims each, at $173,074 in total drug cost. In 2023, CMS named 419 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Pena for performance year 2024, reported through an alternative payment model (APM). Dr. Pena accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 12 papers to Dr. Pena, published from 2020 to 2025. 2025 was the busiest year, with 3. The most frequent topics are Hypertension and Kidney. Dr. Pena has published most often in Am J Med Sci. Dr. Pena's most frequent co-authors are Kenneth Michael Nugent, MD, Gilbert G. Berdine, MD and Boonphiphop Boonpheng, MD.

CMS Open Payments shows 49 general payments to Dr. Pena from 13 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 81% of the total. Relypsa, Inc. paid the most, $252.

Dr. Pena graduated from El Bosque University in 2010. Dr. Pena is a member of ACP.

Dr. Pena is in network with 20 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.